Smith & Nephew SNATS Inc (SNN) Shares Outstanding 2006–TTM

Name: Smith & Nephew SNATS Inc (SNN) shares outstanding history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-04

Smith & Nephew SNATS Inc annual shares outstanding for fiscal TTM was 436 million shares, an increase of 0.0% from 436 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

SNN Annual Shares Outstanding

Shares Outstanding (annual)	TTM → 2025-12-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Shares Outstanding (M)	436M	436M	438M	218M	438M	439M	438M	438M	438M	438M	446M	436M	450M	453M	450M	448M	444M	443M	445M	464M	472M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNN Quarterly Shares Outstanding

Shares Outstanding (quarterly)	2025-12-31	2025-06-30	2024-12-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Shares Outstanding (M)	436M	440M	440M	437M	873M	873M	873M	435M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

PHG Shares Outstanding — Koninklijke Philips NV ADR
PEN Shares Outstanding — Penumbra Inc
BIO Shares Outstanding — Bio-Rad Laboratories Inc
GMED Shares Outstanding — Globus Medical
BIO.B Shares Outstanding — Bio-Rad Laboratories Inc
GKOS Shares Outstanding — Glaukos Corp

More SNN metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All SNN financial statements → Interactive SNN charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.